Nationwide Recall: Contaminated Cream Spreads Deadly Risk!

A popular eczema cream sold on Amazon and in grocery stores nationwide has been recalled after the U.S. Food and Drug Administration (FDA) confirmed it was contaminated with a dangerous bacteria capable of causing life-threatening infections — and millions of Americans with sensitive skin conditions could be at risk.

Story Snapshot

Pharmacal recalled one lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream after FDA confirmed contamination with Staphylococcus aureus, the bacteria responsible for staph infections.
The affected product — lot 1024088, expiring November 2026 — was distributed nationwide through Amazon, retail stores, and wholesale channels.
The FDA warns the contamination could cause infections ranging from localized skin conditions to potentially fatal outcomes including sepsis and septic shock, particularly for people with weakened immune systems.
No adverse events have been reported so far, but the FDA acted proactively on the contamination finding rather than waiting for consumer injuries to emerge.

What Was Recalled and Where It Was Sold

Pharmacal, based in Jackson, Wisconsin, issued a voluntary recall on May 8, 2026, covering one specific lot of MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream. The recalled lot — identified as lot 1024088 with a UPC of 012277051067 and an expiration date of November 2026 — was distributed nationally to wholesale distributors, retail grocery chains including H-E-B, and online through Amazon.

The recall was conducted with full knowledge of the FDA, making this an official regulatory action rather than a voluntary precautionary measure taken quietly behind closed doors. Consumers who purchased this product through any of those channels should check their lot number immediately and stop using the cream if it matches the recalled batch.

The Contamination Risk the FDA Is Warning About

The FDA confirmed the product was contaminated with Staphylococcus aureus — the bacteria behind staph infections. For most healthy adults, a staph skin infection is serious but treatable. However, the FDA specifically flagged elevated risk for people with weakened immune systems or compromised skin, which is precisely the population most likely to be using an eczema treatment cream. For those individuals, the risks escalate dramatically.

According to the FDA’s official recall notice, potential outcomes from using the contaminated product include skin and skin structure infections, infective endocarditis, bone and joint infections, bloodstream infections, and life-threatening conditions such as sepsis and septic shock. These are not theoretical worst-case scenarios invented for dramatic effect — they are the FDA’s documented risk categories tied directly to Staphylococcus aureus exposure through compromised skin.

No Injuries Reported — But That’s How Recalls Are Supposed to Work

As of the recall announcement, Pharmacal confirmed it had received no reports of adverse events related to this lot. That detail matters and should provide some reassurance to consumers. However, the absence of reported injuries does not mean the recall is overblown. FDA protocol is designed to act on confirmed contamination before people are harmed — not after. Waiting for injury reports before pulling a contaminated product from shelves would be a regulatory failure, not a standard.

MG217 Multi-Symptom Treatment Cream & Skin Protectant Eczema Cream by Pharmacal: Recall – Due to Microbial Contamination https://t.co/FGulpFosCO pic.twitter.com/wkW1qA6oTv

— US FDA MedWatch (@FDAMedWatch) May 13, 2026

This is how a functioning consumer-protection system is supposed to operate: a contamination finding triggers swift action, the product is pulled from distribution, and the public is notified quickly through official FDA channels and major retailers. The system worked here. Consumers who rely on products like this — often people managing chronic skin conditions — deserve exactly this kind of fast, transparent response. Anyone with the recalled product should stop using it, dispose of it safely, and contact Pharmacal or their healthcare provider with any concerns.